Where is Matthew Holt reporting from today? He is at the Novartis Biome Launch Event! And that’s not all, we have some special guest stars for you: Unity Stoakes from StartUpHealth and Zoya Khan from THCB & SMACK.health! Join Jessica Da Massa, as she asks Matthew about what the Novartis’s Biome Event is, updates from StartUp Health (they have a print magazine now!), and talks about JP Morgan Week coming up in January!
In honor of World Mental Health Day, I’m sharing the story of PeaceLove Studios and its founder & artist-in-chief, Jeff Sparr. Jeff‘s built an expressive arts program to help millions cope with mental health disorders after he found painting to help with his OCD.
Healthcare needs a place for non-pharmaceutical, non-digital modes of therapy, and PeaceLove Studios is focused on ramping up awareness about the therapeutic benefits of expressive arts when it comes to mental wellness. Part of the challenge, however, is just starting the conversation and bringing visibility to mental health disorders in the first place. Jeff is hoping to inspire a movement. Tune in to find out how.
Dr. Patti Brennan – #SPM2018 speaker preview “Supporting the Care Between the Care: The Role of the National Library of Medicine”
By ePATIENT DAVE deBRONKART
I’m a supporter of the Society for Participatory Medicine’s second annual conference on Oct. 17 in Boston. This article taken from the SPM “ePatients” blog tells you about just one of the great speakers who’ll be there. Please come join us Register here.–Matthew Holt
Here’s the latest in our series of posts by and about the outstanding speakers we’ve lined up for the Society for Participatory Medicine’s second annual conference on Oct. 17 in Boston, attached to the prestigious Connected Health conference. Register here. (Our #SPM2018 blog series has more about the speakers and activities.)
Since my earliest days in this work – even before our Society was formed – Dr. Patricia Flatley Brennan RN, PhD, FAAN, FACMI (or “Patti,” as she’s known to her many friends and fans) has been one of the most optimistic voices. She’s always been a dedicated, enlightened researcher, academic (at the University of Wisconsin, Madison) and voice of patient participation. On top of that, she was the director of the Robert Wood Johnson Foundation’s terrific Project HealthDesign: Rethinking the Power and Potential of Personal Health Records, which ran from 2006-2014, an absolutely pivotal period in the onset of personal health data. Patti knows that knowledge is power, and that patient power is naturally optimized when patient knowledge is optimized.
So you can imagine how thrilled I was when, in 2016, she was appointed the next Director of America’s National Library of Medicine (NLM). In addition to being extremely participatory, perhaps it’s no coincidence that she’s the first woman nurse and the first nurse in the post.
In a moment I’ll say more about the history of this position, and its significance in the timeline that led to SPM. For now, consider this about her topic at our conference, “the care between the care,” particularly the NLM’s role.
By JOHN EL-MARAGHY
What is the first word that comes into mind when someone says “health” or “health tech?” In 2018, the answer is likely “Opioid” and “Artificial Intelligence (AI).” With a growing public interest in combating opioid abuse and advancing AI, the Robert Wood Johnson Foundation (RWJF) teamed up with Catalyst to launch two innovation challenges on those two topics. The first challenge, “the Opioid Challenge,” was designed to address the opioid crisis and support those affected by the opioid misuse while the second challenge, “the AI and the Healthcare Consumer Challenge,” aimed to leverage AI to assist consumer decision making. The challenges sought innovators and entrepreneurs from all around the world and garnered nearly 200 registrations.
Through a rigorous vetting process, 100 amazing competitors proceeded to phase one and five semi-finalists advanced to phase two. Along the way, expert judges analyzed the submissions on a variety of factors such as scalability, impact, UX/UI and more. The final phase of the challenge, a live pitch, was held at the Health 2.0 Fall Conference in Santa Clara where both the expert judges and the audience had a say in who would take home the grand prize.
Although egg freezing was only approved for general use six years ago, the business is fertile ground for disruption according to Jen Lannon, co-founder of website Freeze.Health.
Jen and her co-founder, Sidonia Swarm, started the site when, through their own consumer research, they found that egg freezing could cost anywhere from $4,000 to $18,000 — at clinics in the same market!
Now that ‘social egg freezing’ is a thing among Millennial women who want to delay motherhood, Freeze.Health hopes to become the go-to resource for price shopping, medical information on the process, and details on the patient experience. Believe it or not, but women rallying around #NoBabiesNow don’t exactly feel like they belong at fertility clinics with so many baby pictures on the walls.
Today on the 52nd episode of Health in 2 Point 00, Jess reports from InsurTechConnect 2018! In this episode, Jess asks Matthew about RockHealth’s $6.8 billion fundraise to date & its $3 Billion raise in Q3, Weight Watcher’s rebranding itself and pushing into the wellness space, and (just in time we might add) Maven, a women’s digital health clinic, series B round of $27 million from Oak HC/FT
By REBECCA FOGG
Hardly a day goes by that I don’t read the term “Disruptive Innovation” cited in relation to health care delivery. This might seem like a good thing, given that our expensive, wasteful, and in some cases frightfully ineffective traditional delivery model is in dire need of transformation. However, the term is frequently misunderstood to refer to any innovation representing a radical departure from an industry’s prior best offerings. In fact, it actually has a very specific definition.
Disruptive Innovation is the phenomenon by which an innovation transforms an existing market or sector by introducing simplicity, convenience, accessibility, and affordability where complication and high cost have become the status quo—eventually completely redefining the industry. It has played out in markets from home entertainment to teeth whitening, and it could make health care delivery more effective by making providers’ care processes, as well as individuals’ own self-care regimes easier and less costly. This, in turn, would reduce the need for both more, and more expensive, interventions over time.
Unfortunately, disruption has been slow to emerge in the health care sector. It’s been thwarted by the broader health care industry’s unique structure, which tends to prioritize the needs of commercial insurers and large employers (who pay the most for consumer care) over those of health care consumers themselves. It also stacks the deck against disruptive entrepreneurs, since established providers effectively control professional licensing requirements, and (along with insurers) access to patients & key delivery partners.
By NIRAN AL-AGBA, MD
A few weeks ago, I saw a young patient who was suffering from an ear infection. It was his fourth visit in eight weeks, as the infection had proven resistant to an escalating series of antibiotics prescribed so far. It was time to bring out a heavier hitter. I prescribed Ciprofloxacin, an antibiotic rarely used in pediatrics, yet effective for some drug-resistant pediatric infections.
The patient was on the state Medicaid insurance and required a so-called prior authorization, or PA, for Ciprofloxacin. Consisting of additional paperwork that physicians are required to fill out before pharmacists can fill prescriptions for certain drugs, PAs boil down to yet another cost-cutting measure implemented by insurers to stand between patients and certain costly drugs.
The PA process usually takes from 48-72 hours, and it’s not infrequent for requests to be denied, even when the physician has demonstrated an undeniable medical need for the drug in question.
I know we have been bombarding you all with a bunch of videos and announcements, but there are some really interesting pieces of health tech that are launching and events that are happening in the Fall. Today I wanted to spotlight another really cool startup that I met with at #TechCrunchDisrupt18 called CY-5 (pronounced Sci-5, trust me I kept calling it C-Y-5). Their company is developing biometric temporary tattoos to track your vitals. Right now their tattoos can measure your heart rate and your inter-cranial pressure. Also, strangely enough, their tattoos are designed and printed onto a special paper that conducts electricity- that means it requires no exterior electricity source to monitor your biometrics! It is all in the design of the product that powers the tattoo. Their focus right now is to test their product out in the elderly population. For all of you out there that can’t get real tattoos, this would look really cool plus it would track your vitals and keep you healthy- double win- Matthew Holt
By JOHN EL-MARAGHY
The New York City Economic Development Corporation and Catalyst @ Health 2.0 are thrilled to announce another round of Digital Health Marketplace matchmaking coming up on December 5th! Since 2013, the Digital Health Marketplace has connected digital health “Sellers” offering technology solutions to a diverse range of healthcare “Buyers” or institutions looking for tech-enabled solutions and partnerships. At the center of the Digital Health Marketplace is the successful curation of needs and solutions that lead to the development of commercialization and the rapid adoption of new health technologies. If you are an early stage startup looking for relevant pilot/commercial partners or a healthcare organization interested in adopting leading technologies, apply for your opportunity to be matched with relevant partners for one-on-one, in-person sales meetings.